Tag: Vaccines
Timing of COVID-19 Vaccination in Pregnancy Examined
Maternal anti-spike IgG levels detectable at delivery regardless of timing of vaccination; levels highest with early third-trimester vaccination
CDC Backs Boosters for High-Risk Children Ages 5 to 11 Years
Agency also endorses shorter time between shots
FDA Approves Pfizer Booster Shots for Children Ages 12 to 15
Agency also reduced the period people must wait between their second dose and booster shot from six to five months
BNT162b2 Still Effective, but Less So, Against Omicron
Vaccine effectiveness 70 percent compared with 93 percent against hospitalization for COVID-19 during delta predominance
Israel Will Give Fourth COVID-19 Shot to People Older Than 60, Health Workers
About 60 percent of Israel's 9.4 million people are fully vaccinated with either a recent second dose or booster dose
Physician’s Briefing Weekly Coronavirus Roundup
Adverse Events Rare After BNT162b2 Vaccine in 5- to 11-Year-Olds
Data show 4,249 reports of adverse events after about 8.7 million doses of vaccine were administered; 97.6 percent not serious
BNT162b2 Vaccine Effectiveness 92 Percent for Teens Ages 12 to 17
Estimated vaccine effectiveness of full Pfizer-BioNTech vaccination 92 percent for preventing SARS-CoV-2 infection
FDA May Allow Pfizer Boosters for 12- to 15-Year-Olds by Monday
Agency also expected to reduce the amount of time adolescents and adults must wait between their second dose of vaccine and booster
No Effect on Ovarian Reserve Seen After mRNA COVID-19 Vaccination
Mean levels of anti-Müllerian hormone unchanged from baseline to three months after vaccination among reproductive-aged women
